SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,828,000 | +186.1% | 11,400 | +74.5% | 0.37% | +76.8% |
Q1 2020 | $639,000 | -37.4% | 6,532 | -30.1% | 0.21% | -48.8% |
Q4 2018 | $1,020,000 | -13.7% | 9,350 | +27.7% | 0.41% | +0.5% |
Q3 2018 | $1,182,000 | +2.3% | 7,320 | -16.2% | 0.41% | -7.2% |
Q2 2018 | $1,155,000 | -50.5% | 8,740 | -72.3% | 0.44% | -60.8% |
Q1 2018 | $2,335,000 | +106.6% | 31,520 | +55.2% | 1.13% | +73.8% |
Q4 2017 | $1,130,000 | +122.0% | 20,305 | +81.0% | 0.65% | +103.4% |
Q3 2017 | $509,000 | +53.3% | 11,220 | +107.6% | 0.32% | -24.0% |
Q3 2016 | $332,000 | – | 5,405 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |